CD226 and B-cell chronic lymphocytic leukemia: Given the pronounced difference in CD226 frequency/expression between high‐ and low‐risk CLL patients within the EFF and EM CD8+ T cell subsets, we further investigated the consistency of this observation in the EFF and EM CD8+ T cell subpopulations.